Sheila Gujrathi has an estimated net worth of $9.82 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., Receptos, Inc., Ventyx Biosciences, Inc., Gossamer Bio, Inc., Janux Therapeutics, Inc., and FIVE PRIME THERAPEUTICS INC.

2024 was Sheila Gujrathi's most active year for acquiring shares with 7 total transactions. Sheila Gujrathi's most active month to acquire stocks was the month of May. 2026 was Sheila Gujrathi's most active year for disposing of shares, totalling 8 transactions. Sheila Gujrathi's most active month to dispose stocks was the month of February. 2023 saw Sheila Gujrathi paying a total of $603,000.00 for 128,437 shares, this is the most they've acquired in one year. In 2015 Sheila Gujrathi cashed out on 344,645 shares for a total of $44,119,054.22, their largest year based on trade value.